71.31
Arcellx Inc Borsa (ACLX) Ultime notizie
What analysts say about Arcellx Inc. stockRapid wealth multiplication - PrintWeekIndia
What drives Arcellx Inc. stock priceSuperior portfolio returns - PrintWeekIndia
What analysts say about Arcellx Inc. stock outlookBreakthrough investment results - jammulinksnews.com
How to Take Advantage of moves in (ACLX) - news.stocktradersdaily.com
Victory Capital Management Inc. Sells 6,073 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx, Inc. (NASDAQ:ACLX) Given Average Recommendation of “Buy” by Analysts - Defense World
Arcellx Inc. Stock Analysis and ForecastConsistently exceptional gains - jammulinksnews.com
Is Arcellx Inc. a good long term investmentFree Trading Strategy Suggestions - jammulinksnews.com
Bank of New York Mellon Corp Cuts Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Principal Financial Group Inc. Sells 184 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Xponance Inc. Acquires 190 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx Advances Phase 3 Study for Multiple Myeloma Treatment - The Globe and Mail
There's Reason For Concern Over Arcellx, Inc.'s (NASDAQ:ACLX) Price - 富途牛牛
Teacher Retirement System of Texas Decreases Stake in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx; Anito-Cel With D-Domain Differentiation Looks To Capture R/R MM Market (ACLX) - Seeking Alpha
What makes Arcellx Inc. stock price move sharplyElite Stock Shortlist - Newser
Why Arcellx Inc. stock attracts strong analyst attentionFree High-Accuracy Stock Picks - Newser
GAMMA Investing LLC Buys 252 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Amalgamated Bank Buys 161 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Allspring Global Investments Holdings LLC Has $468,000 Stock Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
How might ACLX's 2025 Q1 EPS forecast affect strategies? - AInvest
Piper Sandler maintains Overweight rating on Arcellx stock amid CAR-T safety study - Investing.com Nigeria
(ACLX) Investment Report - news.stocktradersdaily.com
FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers - Benzinga
(ACLX) Trading Signals - news.stocktradersdaily.com
Citi initiates Arcellx stock with buy rating on cell therapy potential - Investing.com
Citi initiates Arcellx stock with buy rating on cell therapy potential By Investing.com - Investing.com South Africa
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):